The EMJ Podcast | Episode 224
This week, Jonathan is joined by John ‘Jack’ Cush, Director of Clinical Rheumatology at the Baylor Research Institute, Dallas, Texas, USA. The two doctors explore novel treatment avenues for rheumatic diseases, and discuss the exciting potential of AI and telemedicine.
Spotify | Apple | Amazon Music | Download MP3 (47 mins)
John J Cush is Director of Clinical Rheumatology at the Baylor Research Institute, and Professor of Medicine and Rheumatology, Baylor University Medical Center, Dallas, Texas, USA. A leading figure in rheumatology, Cush is known for his extensive contributions to clinical research, medical education, and digital platforms. He currently serves as the Executive Editor of RheumNow.com, a news and education network dedicated to the field, and is co-editor of the online textbook RheumaKnowledgy.
With a focus on translational immunology, drug development, and safety, Cush has published over 150 journal articles and been a key player in numerous clinical trials, contributing to the development of critical therapies in rheumatoid arthritis. His recent work includes evaluating the impact of telemedicine in rheumatology, the management of reproductive health in rheumatic diseases, and the safety of JAK inhibitors
- 00:00 Introduction
- 02:29 The history of beer and rock’ n roll
- 06:10 Transitioning into digital medical education
- 10:21 Jack’s podcast: RheumNow
- 14:30 Challenges in lupus diagnosis and management
- 16:58 IL-5 inhibitors: novel drugs for allergic vasculitis
- 19:22 How does diet affect inflammation and bone health?
- 24:22 Telemedicine in rheumatology
- 29:26 Lessons in rheumatoid arthritis care
- 33:30 Soaring costs in healthcare
- 36:40 New horizons in rheumatoid arthritis treatment
- 41:37 The future of AI
- 43:30 Jack’s three wishes for rheumatology
